- Home
- Publications
- Publication Search
- Publication Details
Title
Osteoporosis and Cancer
Authors
Keywords
Bone, Cancer, Osteoporosis, Breast, Aromatase inhibitor, Prostate, Myeloma, Bisphosphonate, Denosumab, Exercise, Vitamin D, Calcium
Journal
Current Osteoporosis Reports
Volume 11, Issue 3, Pages 163-170
Publisher
Springer Nature
Online
2013-07-23
DOI
10.1007/s11914-013-0154-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
- (2013) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Bone Mineral Density Screening Among Women with a History of Breast Cancer Treated with Aromatase Inhibitors
- (2013) Leslie Spangler et al. JOURNAL OF WOMENS HEALTH
- Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D
- (2013) S. M. H. Alibhai et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis Management Program Decreases Incidence of Hip Fracture in Patients With Prostate Cancer Receiving Androgen Deprivation Therapy
- (2013) Ali-Asghar Zhumkhawala et al. UROLOGY
- Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
- (2012) R. Coleman et al. ANNALS OF ONCOLOGY
- Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy
- (2012) Alicia K. Morgans et al. CANCER
- Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic Acid
- (2012) M. Martin et al. CLINICAL CANCER RESEARCH
- Male Osteoporosis
- (2012) Matthew T. Drake et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
- (2012) Fatima Cardoso et al. EUROPEAN JOURNAL OF CANCER
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy
- (2012) Richard Choo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy
- (2012) Shabbir M. H. Alibhai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefits and Risks of Bisphosphonate Therapy for Osteoporosis
- (2012) Sundeep Khosla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Bisphosphonates on Bone Mineral Density and Fracture Prevention in Gastric Cancer Patients After Gastrectomy
- (2012) Jung Sub Lim et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cost Effectiveness of Fracture Prevention in Postmenopausal Women Who Receive Aromatase Inhibitors for Early Breast Cancer
- (2012) Kouta Ito et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Dynamics of Bone Mineral Density During Intermittent Androgen Deprivation for Men With Nonmetastatic, Hormone-Sensitive Prostate Cancer
- (2012) Evan Y. Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer
- (2012) Matthew R. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic Review of Bone Health in Older Women Treated with Aromatase Inhibitors for Early-Stage Breast Cancer
- (2012) Taryn Becker et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2012) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial
- (2012) Angela M Cheung et al. LANCET ONCOLOGY
- Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- (2012) Alexander HG Paterson et al. LANCET ONCOLOGY
- Calcium and Vitamin D Supplementation During Androgen Deprivation Therapy for Prostate Cancer: A Critical Review
- (2012) M. Datta et al. ONCOLOGIST
- Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
- (2011) P. Hadji et al. ANNALS OF ONCOLOGY
- Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1 levels in patients with MGUS
- (2011) A. C. Ng et al. BLOOD
- Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial
- (2011) Kerri M. Winters-Stone et al. BREAST CANCER RESEARCH AND TREATMENT
- Final 5-year results of Z-FAST trial
- (2011) Adam M. Brufsky et al. CANCER
- Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial
- (2011) Antonio Llombart et al. Clinical Breast Cancer
- Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
- (2011) Siddhartha Ganguly et al. CLINICAL TRANSPLANTATION
- Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial
- (2011) Sharon Kilbreath et al. Contemporary Clinical Trials
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysis
- (2011) Eitan Amir et al. JNCI-Journal of the National Cancer Institute
- Toremifene Decreases Vertebral Fractures in Men Younger Than 80 Years Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2011) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
- (2011) Matthew R Smith et al. LANCET
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of osteoporosis among cancer patients in Germany
- (2011) M. Reuss-Borst et al. OSTEOPOROSIS INTERNATIONAL
- Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial
- (2011) T. Saarto et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- The Home-Based Older People's Exercise (HOPE) trial: study protocol for a randomised controlled trial
- (2011) Andrew Clegg et al. Trials
- OSTEOPOROSIS IN PATIENTS WITH PROSTATE CANCER ON LONG-TERM ANDROGEN DEPRIVATION THERAPY: AN INCREASING, BUT UNDER-RECOGNIZED PROBLEM
- (2010) Janet E. Brown et al. BJU INTERNATIONAL
- Effects of a Structured Weight-Bearing Exercise Program on Bone Metabolism Among Breast Cancer Survivors: A Feasibility Trial
- (2010) Luke J. Peppone et al. Clinical Breast Cancer
- Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women
- (2010) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis of the US, German, Netherlands, and Belgium sub-studies
- (2010) Peyman Hadji et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonate Therapeutics in Bone Disease: The Hard and Soft Data on Osteoclast Inhibition
- (2010) M. T. Drake et al. MOLECULAR INTERVENTIONS
- The Use of Zoledronic Acid in Men Receiving Androgen Deprivation Therapy for Prostate Cancer With Severe Osteopenia or Osteoporosis
- (2010) Steven C. Campbell et al. UROLOGY
- Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
- (2009) M. Rabaglio et al. ANNALS OF ONCOLOGY
- The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial
- (2009) G.J. van Londen et al. BONE
- Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study
- (2009) Georgiana K. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer
- (2009) Eugene McCloskey et al. EUROPEAN JOURNAL OF CANCER
- Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
- (2009) Dawn L. Hershman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
- (2009) Nirmala Bhoopalam et al. JOURNAL OF UROLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial
- (2009) N. L. Waltman et al. OSTEOPOROSIS INTERNATIONAL
- Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention
- (2009) S. Nicole Culos-Reed et al. SUPPORTIVE CARE IN CANCER
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- The Effects of Alendronate Treatment in Osteoporotic Patients Affected by Monoclonal Gammopathy of Undetermined Significance
- (2008) Jessica Pepe et al. CALCIFIED TISSUE INTERNATIONAL
- Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss
- (2008) J. R. Berenson et al. CLINICAL CANCER RESEARCH
- Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now